does tirzepatide affect liver enzymes Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic disease by reducing the expression of CD36 and OBP2A Is Tirzepatide Hard on Liver?

22, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice

Learn why it happens and practical tips to manage it safely.

Most patients continue treatment for 6 months to several years to achieve and maintain meaningful weight reduction

This guide explains the science behind dual-pathway metabolic therapy and how PlexusDx personalizes GLP-1 treatment for your genetic profile

Device and Health Care Groups have developed an initial checklist for providers to consider during the FDA’s enforcement discretion period.

Agents and brokers must stay vigilant, informed, and adaptable as our industry continues to evolve at an unprecedented pace